1 - 25 of 8
Number of results to display per page
TitleCreatorDate
1 Sharp Edge Eye Syndrome: A Case Report and Survey of Self-Identified IndividualsMerrick S. Reynolds; Bradley J. Katz; Kathleen B. Digre; Ben J. Brintz; Lenora M. Olson; Judith E. A. Warner2022-12
2 The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative StudyBenson S. Chen; Erik Holzinger; Magali Taiel; Patrick Yu-Wai-Man2022-09
3 Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi ApproachRaymond S. Douglas; Andrea L. Kossler; Jody Abrams; Cesar A. Briceño; David Gay; Andrew Harrison; Michael Lee; John Nguyen; Shannon S. Joseph; Dianne Schlachter; Jeremy Tan; Judah Lynch; Louisa Oliver; Richard Perry; Shoaib Ugradar2022-09
4 Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine PatientsJavier A Membrilla; Íñigo de Lorenzo; Lucía Sánchez-Casado; María Sastre; Javier Díaz de Terán2022-09
5 Rehabilitation of Visual Loss: Where We Are and Where We Need to BeBehzad Mansouri, MD, PhD, FRCPC; Marinya Roznik, Bsc; Joseph F. Rizzo III, MD; Sashank Prasad, MD2018-06
6 More Than Meets the Eye: The Eye and Migraine -- What You Need to KnowKathleen B. Digre, MD2018-06
7 Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialMartin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
8 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
1 - 25 of 8